Works matching IS 00070920 AND DT 2008 AND VI 98 AND IP 1

Results: 46
    1
    2
    3
    4

    Quality of life and quality-adjusted survival (Q-TWiST) in patients receiving dose-intensive or standard dose chemotherapy for high-risk primary breast cancer.

    Published in:
    British Journal of Cancer, 2008, v. 98, n. 1, p. 25, doi. 10.1038/sj.bjc.6604092
    By:
    • Bernhard, J.;
    • Zahrieh, D.;
    • Zhang, J. J.;
    • Martinelli, G.;
    • Basser, R.;
    • Hürny, C.;
    • Forbes, J. F.;
    • Aebi, S.;
    • Yeo, W.;
    • Thürlimann, B.;
    • Green, M. D.;
    • Colleoni, M.;
    • Gelber, R. D.;
    • Castiglione-Gertsch, M.;
    • Price, K. N.;
    • Goldhirsch, A.;
    • Coates, A. S.
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours.

    Published in:
    British Journal of Cancer, 2008, v. 98, n. 1, p. 80, doi. 10.1038/sj.bjc.6604108
    By:
    • Eskens, F. A. L. M.;
    • Mom, C. H.;
    • Planting, A. S. T.;
    • Gietema, J. A.;
    • Amelsberg, A.;
    • Huisman, H.;
    • van Doorn, L.;
    • Burger, H.;
    • Stopfer, P.;
    • Verweij, J.;
    • de Vries, E. G. E.
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25

    A combination of gefitinib and FOLFOX-4 as first-line treatment in advanced colorectal cancer patients. A GISCAD multicentre phase II study including a biological analysis of EGFR overexpression, amplification and NF-kB activation.

    Published in:
    British Journal of Cancer, 2008, v. 98, n. 1, p. 71, doi. 10.1038/sj.bjc.6604121
    By:
    • Cascinu, S.;
    • Berardi, R.;
    • Salvagni, S.;
    • Beretta, G. D.;
    • Catalano, V.;
    • Pucci, F.;
    • Sobrero, A.;
    • Tagliaferri, P.;
    • Labianca, R.;
    • Scartozzi, M.;
    • Crocicchio, F.;
    • Mari, E.;
    • Ardizzoni, A.
    Publication type:
    Article
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42

    Use of NSAIDs, smoking and lung cancer risk.

    Published in:
    British Journal of Cancer, 2008, v. 98, n. 1, p. 232, doi. 10.1038/sj.bjc.6604151
    By:
    • Olsen, J. H.;
    • Friis, S.;
    • Poulsen, A. H.;
    • Fryzek, J.;
    • Harving, H.;
    • Tjønneland, A.;
    • Sørensen, H. T.;
    • Blot, W.
    Publication type:
    Article
    43
    44
    45
    46